Today Raymond James Reiterates a Buy Rating on UnitedHealth (NYSE:UNH) and a $310.0000 Target Price

UnitedHealth Group Incorporated (NYSE:UNH) Logo

Investors sentiment increased to 1.1 in 2018 Q2. Its up 0.14, from 0.96 in 2018Q1. It increased, as 39 investors sold UnitedHealth Group Incorporated shares while 504 reduced holdings. 132 funds opened positions while 463 raised stakes. 792.19 million shares or 0.38% more from 789.19 million shares in 2018Q1 were reported.

Walleye Trading Limited Liability holds 0.01% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH) for 4,823 shares. First Personal Svcs accumulated 5,343 shares. Driehaus Mngmt Ltd Liability owns 2,135 shares. Usca Ria Lc accumulated 5,769 shares. Rhumbline Advisers accumulated 1.57 million shares. Buckingham Asset Management Ltd reported 0.6% stake. Eastern Bancorp accumulated 64,295 shares. Mount Lucas Management Ltd Partnership has 10,740 shares for 0.4% of their portfolio. Art Advsr Ltd invested in 46,000 shares or 0.46% of the stock. Intact Inv Mngmt owns 3,000 shares for 0.03% of their portfolio. Azimuth Cap Mgmt Limited Liability Com holds 1.1% or 62,414 shares in its portfolio. Woodley Farra Manion Port Mngmt accumulated 916 shares. Telemus Ltd Limited Liability Company invested 0.61% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). 8,274 are held by Ami Management. First Commonwealth Financial Corporation Pa reported 0.22% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH).

Since June 15, 2018, it had 0 insider buys, and 11 sales for $29.90 million activity. 10,000 shares valued at $2.65 million were sold by BURKE RICHARD T on Thursday, September 13. The insider Nelson Steven H sold $2.16M. Shine Kenneth Irwin had sold 163 shares worth $44,796. Shares for $1.32M were sold by HOOPER MICHELE J. Another trade for 15,393 shares valued at $4.07 million was sold by WILSON D ELLEN. The insider WILENSKY GAIL R sold 3,090 shares worth $779,001.

UnitedHealth (NYSE:UNH) Rating Reaffirmed

New York: In a report sent to investors and clients on 28 November, Raymond James restate their Buy rating on UnitedHealth (NYSE:UNH) shares. They now have a $310.0000 price target on the company. Raymond James’s target means a potential upside of 10.18 % from the company’s previous stock close.

UnitedHealth Group Incorporated (NYSE:UNH) Ratings Coverage

Among 11 analysts covering UnitedHealth Group (NYSE:UNH), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. UnitedHealth Group has $320 highest and $27000 lowest target. $297’s average target is 5.56% above currents $281.36 stock price. UnitedHealth Group had 17 analyst reports since June 7, 2018 according to SRatingsIntel. Raymond James maintained UnitedHealth Group Incorporated (NYSE:UNH) rating on Monday, September 24. Raymond James has “Strong Buy” rating and $304 target. Credit Suisse downgraded the stock to “Hold” rating in Monday, June 11 report. The firm has “Buy” rating by Raymond James given on Wednesday, November 28. The stock has “Overweight” rating by Morgan Stanley on Wednesday, September 5. The company was maintained on Friday, October 12 by Barclays Capital. The stock has “Neutral” rating by Citigroup on Monday, September 10. The stock has “Outperform” rating by BMO Capital Markets on Thursday, June 7. RBC Capital Markets maintained the stock with “Outperform” rating in Wednesday, July 18 report. The stock has “Outperform” rating by BMO Capital Markets on Thursday, June 21. As per Wednesday, October 17, the company rating was maintained by Raymond James.

The stock decreased 0.10% or $0.29 during the last trading session, reaching $281.36. About 6.14M shares traded or 82.20% up from the average. UnitedHealth Group Incorporated (NYSE:UNH) has risen 33.02% since December 2, 2017 and is uptrending. It has outperformed by 17.40% the S&P500.

Analysts await UnitedHealth Group Incorporated (NYSE:UNH) to report earnings on January, 15. They expect $3.22 EPS, up 24.32 % or $0.63 from last year’s $2.59 per share. UNH’s profit will be $3.10B for 21.84 P/E if the $3.22 EPS becomes a reality. After $3.41 actual EPS reported by UnitedHealth Group Incorporated for the previous quarter, Wall Street now forecasts -5.57 % negative EPS growth.

UnitedHealth Group Incorporated operates as a diversified health and well-being firm in the United States. The company has market cap of $270.68 billion. The companyÂ’s UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, individuals, and military service members; and health care coverage, and health and well-being services to individuals aged 50 and older addressing their needs for preventive and acute health care services. It has a 22.08 P/E ratio. It also provides services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, ChildrenÂ’s Health Insurance Program, and health care programs; and health services, including commercial health and dental benefits.

More notable recent UnitedHealth Group Incorporated (NYSE:UNH) news were published by: Seekingalpha.com which released: “Midterm Elections – Cramer’s Mad Money (11/6/18) – Seeking Alpha” on November 07, 2018, also Fool.com with their article: “Stock Market Power Rankings: Apple’s $190 Billion Haircut – The Motley Fool” published on November 18, 2018, Fool.com published: “Stock Market Power Rankings: Save Us, Amazon – The Motley Fool” on November 25, 2018. More interesting news about UnitedHealth Group Incorporated (NYSE:UNH) were released by: 247Wallst.com and their article: “Democrats’ Congressional Win Could Be Huge for 4 Top Health Care Stocks – 24/7 Wall St.” published on November 30, 2018 as well as Investorplace.com‘s news article titled: “10 Value Stocks to Buy for December – Investorplace.com” with publication date: November 30, 2018.

UnitedHealth Group Incorporated (NYSE:UNH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.